Future studies are needed to determine if RGS16 can inhibit cell migration and invasion through other pathways such as the SDF-1/CxCR4 pathway which is deregulated in pancreatic cancer ([21]). This evidence concerns the gene CXCR4 and pancreatic neoplasm.